MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > SOME CLARITY PLEASE !! NOT smokescreens

<< Previous

Bullboard Posts

Next >>

Comment by goldyhawkon Mar 25, 2024 11:43am

93 Views

Post# 35950835

RE:RE:RE:SOME CLARITY PLEASE !! NOT smokescreens

HC. had 26 questions for Medmira on the latest syphilis submissions

this shareholder and maybe others have that many or more about Medmira projects

Some updates on the many many many Medmira projects are necessary (I think)or would be appreciated in the UPCOMING MEDMIRA MD&A

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market